| First Author | Du S | Year | 2021 |
| Journal | Aging Cell | Volume | 20 |
| Issue | 8 | Pages | e13432 |
| PubMed ID | 34247441 | Mgi Jnum | J:310745 |
| Mgi Id | MGI:6755053 | Doi | 10.1111/acel.13432 |
| Citation | Du S, et al. (2021) FoxO3 deficiency in cortical astrocytes leads to impaired lipid metabolism and aggravated amyloid pathology. Aging Cell 20(8):e13432 |
| abstractText | The rise of life expectancy of the human population is accompanied by the drastic increases of age-associated diseases, in particular Alzheimer's disease (AD), and underscores the need to understand how aging influences AD development. The Forkhead box O transcription factor 3 (FoxO3) is known to mediate aging and longevity downstream of insulin/insulin-like growth factor signaling across species. However, its function in the adult brain under physiological and pathological conditions is less understood. Here, we report a region and cell-type-specific regulation of FoxO3 in the central nervous system (CNS). We found that FoxO3 protein levels were reduced in the cortex, but not hippocampus, of aged mice. FoxO3 was responsive to insulin/AKT signaling in astrocytes, but not neurons. Using CNS Foxo3-deficient mice, we reveal that loss of FoxO3 led to cortical astrogliosis and altered lipid metabolism. This is associated with impaired metabolic homoeostasis and beta-amyloid (Abeta) uptake in primary astrocyte cultures. These phenotypes can be reversed by expressing a constitutively active FOXO3 but not a FOXO3 mutant lacking the transactivation domain. Loss of FoxO3 in 5xFAD mice led to exacerbated Abeta pathology and synapse loss and altered local response of astrocytes and microglia in the vicinity of Abeta plaques. Astrocyte-specific overexpression of FOXO3 displayed opposite effects, suggesting that FoxO3 functions cell autonomously to mediate astrocyte activity and also interacts with microglia to address Abeta pathology. Our studies support a protective role of astroglial FoxO3 against brain aging and AD. |
